Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening

被引:53
作者
Xing, Li [1 ,2 ]
McDonald, Joseph J. [1 ]
Kolodziej, Steve A. [1 ]
Kurumbail, Ravi G. [1 ]
Williams, Jennifer M. [1 ]
Warren, Chad J. [1 ]
O'Neal, Janet M. [1 ]
Skepner, Jill E. [1 ]
Roberds, Steven L. [1 ]
机构
[1] Pfizer Global Res & Dev, Chesterfield, MO 63017 USA
[2] Pfizer Global Res & Dev, Cambridge, MA 02140 USA
关键词
BIOCHEMICAL-EVIDENCE; CATALYTIC MECHANISM; NITROGEN; DOCKING; INVOLVEMENT; PHOSPHATASE; PREDICTION; EVOLUTION; PATHWAYS; REVEALS;
D O I
10.1021/jm101382t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based virtual screening was applied to design combinatorial libraries to discover novel and potent soluble epoxide hydrolase (sEH) inhibitors. X-ray crystal structures revealed unique interactions for a benzoxazole template in addition to the conserved hydrogen bonds with the catalytic machinery of sEH. By exploitation of the favorable binding elements, two iterations of library design based on amide coupling were employed, guided principally by the docking results of the enumerated virtual products. Biological screening of the libraries demonstrated as high as 90% hit rate, of which over two dozen compounds were single digit nanomolar sEH inhibitors by 105,0 determination. In total the library design and synthesis produced more than 300 submicromolar sEH inhibitors. In cellular systems consistent activities were demonstrated with biochemical measurements. The SAR understanding of the benzoxazole template provides valuable insights into discovery of novel sEH inhibitors as therapeutic agents.
引用
收藏
页码:1211 / 1222
页数:12
相关论文
共 39 条
[31]   Testing Assumptions and Hypotheses for Rescoring Success in Protein-Ligand Docking [J].
O'Boyle, Noel M. ;
Liebeschuetz, John W. ;
Cole, Jason C. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (08) :1871-1878
[32]   MOLECULAR AND BIOCHEMICAL-EVIDENCE FOR THE INVOLVEMENT OF THE ASP-333-HIS-523 PAIR IN CATALYTIC MECHANISM OF SOLUBLE EPOXIDE HYDROLASE [J].
PINOT, F ;
GRANT, DF ;
BEETHAM, JK ;
PARKER, AG ;
BORHAN, B ;
LANDT, S ;
JONES, AD ;
HAMMOCK, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7968-7974
[33]   Soluble epoxide hydrolase is a therapeutic target for acute inflammation [J].
Schmelzer, KR ;
Kubala, L ;
Newman, JW ;
Kim, IH ;
Eiserich, JP ;
Hammock, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (28) :9772-9777
[34]   Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function [J].
Spector, AA ;
Fang, X ;
Snyder, GD ;
Weintraub, NL .
PROGRESS IN LIPID RESEARCH, 2004, 43 (01) :55-90
[35]   Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase [J].
Tran, KL ;
Aronov, PA ;
Tanaka, H ;
Newman, JW ;
Hammock, BD ;
Morisseau, C .
BIOCHEMISTRY, 2005, 44 (36) :12179-12187
[36]   Towards improving compound selection in structure-based virtual screening [J].
Waszkowycz, Bohdan .
DRUG DISCOVERY TODAY, 2008, 13 (5-6) :219-226
[37]   Formation of nitrogen-containing heterocycles using di(imidazole-1-yl)methanimine [J].
Wu, YQ ;
Limburg, DC ;
Wilkinson, DE ;
Hamilton, GS .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2003, 40 (01) :191-193
[38]   Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase [J].
Yamada, T ;
Morisseau, C ;
Maxwell, JE ;
Argiriadi, MA ;
Christianson, DW ;
Hammock, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :23082-23088
[39]   Epoxygenase pathways of arachidonic acid metabolism [J].
Zeldin, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (39) :36059-36062